Protection of dogs against canine distemper by vaccination with a canarypox virus recombinant expressing canine distemper virus fusion and hemagglutinin glycoproteins

American Journal of Veterinary Research

Volumn 58, Issue 8, 1997, Pages 833-836

  Pardo, M Camila ^a   Bauman, John E ^a   Mackowiak, Marc ^a  

^a Rhone Merieux Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; RECOMBINANT VACCINE; VIRUS ANTIBODY; VIRUS HEMAGGLUTININ; VIRUS VACCINE;

ANIMAL; ARTICLE; BLOOD; CANINE DISTEMPER MORBILLIVIRUS; DOG; DOG DISEASE; FEMALE; FOWLPOX VIRUS; IMMUNOLOGY; INCIDENCE; MALE; MORBIDITY; MORTALITY;

ANIMALS; ANTIBODIES, VIRAL; AVIPOXVIRUS; DISTEMPER; DISTEMPER VIRUS, CANINE; DOGS; FEMALE; HEMAGGLUTININS, VIRAL; INCIDENCE; MALE; MORBIDITY; RECOMBINANT FUSION PROTEINS; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 0031201457     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Appel MJG, Yates RA, Foley AL, et al. Canine distemper virus epizootic in lions, tigers, and leopards in North America. J Vet Diagn Invest 1994;6:277-288.
2. Harder TC, Kenter M, Vos H, et al. Canine distemper virus from diseased large felids: biological properties and phylogenetic relationships. J Gen Virol 1996;77:397-405.
3. Greene CE. In: Greene CE, ed. Infectious disease of the dog and cat. Philadelphia: WB Saunders Co, 1990;226-241.
4. Norrby E, Utter G, Orvell C, et al. Protection against CDV in dogs after immunization with isolated F glycoprotein. J Virol 1986;58:536-541.
5. De Vries TC, Vytdenhaag FGC, Osterhaus A, et al. CDV iscoms, but not measles virus iscoms protect dogs against CDV infection. J Gen Virol 1986;69:536-541.
6. Dudley JM, Nixon A, Mumford AM. Distemper and measles vaccine-a comparative trial. J Small Anim Pract 1978;19:463-468.
7. Stephensen CB, Welter J, Thaker SR, et al. Ferrets as a model for Morbillivirus infections and vaccination with ALVAC and NYVAC-based CDV recombinants expressing the CDV HA and F glycoproteins. J Virol 1997;71:1506-1513.
8. Paoletti E, Taylor J, Meignier B, et al. Highly attenuated poxvirus vector; NYVAC, ALVAC, and TROVAC. Dev Biol Stand 1995;159-163.
9. Pincus S, Tartaglia J, Paoletti E. Poxvirus-based vector as vaccine candidates. Biologicals 1995;23:159-164.
10. Taylor J, Weinberg R, Tartaglia J, et al. Non-replicating viral vectors as potential vaccines: recombinant canarypox virus expressing measles fusion (F) and hemagglutinin (HA) glycoproteins. Virology 1992;187:321-328.
11. Wild FP, Giraudon D, Spehner R, et al. Fowlpox virus recombinant encoding the measles virus fusion protein: protection of mice against fatal measles encephalitis. Vaccine 1990;8:441-446.
12. Pardo MC, Mackowiak M. Canine distemper immunization by recombinant vaccines, in Proceedings. IBC Intern Symp 1994.
13. Appel MJG, Robson DS. A micro-neutralization test for CDV. Am J Vet Res 1973;34:1459-1463.
14. Pialoux G, Excler JL, Riviere Y, et al. A prime-boost approach to HIV preventive vaccine using a recombinant canarypox virus expressing glycoprotein 160 (MN) followed by a recombinant glycoprotein 160 (MN/LAI). AIDS Res Hum Retrovirus 1995;11: 373-381.
15. Egan MA, Pavlat WA, Tartaglia J, et al. Induction of HIV-1-specific cytolytic T lymphocyte responses in seronegative adults by non-replicating, host-range-restricted canarypox vector (ALVAC) carrying the HIV-1MN env gene. J Infect Dis 1995;171:1623-1627.
16. Franchini G, Tartaglia J, Markham P, et al. Highly attenuated HTLV type 1 env poxvirus vaccines induce protection against a cell-associated HTLV type 1 challenge in rabbits. AIDS Res Hum Retrovirus 1995;11:307-313.
17. Tartaglia J, Jarret O, Neil JC, et al. Protection of cats against feline leukemia virus by vaccination with a canarypox virus recombinant, ALVAC-FL. J Virol 1995;67:2370-2375.
18. Cox WI, Tartaglia J, Paoletti E. Induction of cytotoxic T lymphocytes by recombinant canarypox (ALVAC) and attenuated vaccinia (NYVAC) viruses expressing the HIV-1 envelope glycoprotein. Virology 1993;195:845-850.
19. Plotkin SA, Cadoz M, Meignier B, et al. The safety and use of canarypox vectored vaccines. Dev Biol Stan 1995;84:164-170.
20. Cornwell HJC, Thompson H, McCandish IAP, et al. Encephalitis in dogs associated with a batch of canine distemper (Rockborn) vaccine. Vet Rec 1988;16:54-59.
21. Pearce KS, Mitchell WJ, Summers BA, et al. Virulent and attenuatted canine distemper virus infects multiple dog brain cell types in vitro. Glia 1991;4:408-416.
22. Hartley WJ. A post-vaccinal inclusion body encephalitis. Vet Pathol 1974;11:301-312.
23. Cadoz M, Strady A, Meignier B, et al. Immunization with canarypox virus expressing rabies glycoprotein. Lancet 1992;339: 1429-1432.